Search - tctmd.com

Displaying 141 - 160 of 206

Sort: Relevancy | Date

Presentation TCT 2016

Stable Angina Decision-making: PCI vs CABG vs OMT

Presenter: Tayo A. Addo, Robert T. Pyo

October 30, 2016

News Conference News TCT 2015

Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years

October 16, 2015

$Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!$

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

$Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina$

Presentation TCT 2015

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Presenter: Greg L. Kaluza, Joachim Schofer, Timothy D. Henry

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Conference News TCT 2015

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Yael L. Maxwell

October 13, 2015

News Conference News TCT 2015

PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

Presentation TCT 2015

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

Stable Angina: PCI vs CABG vs OMT

Presenter: George D. Dangas, Robert T. Pyo

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

September 18, 2014

News Conference News TCT 2014

Microvascular Dysfunction Prevalent in Patients with Chest Pain, Non-Obstructive CAD

September 18, 2014

Presentation TCT 2014

Absorb III/IV: Angina and Ischemia Hypotheses

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation TCT 2014

TCT 102: Incidence of Angina and Chest Pain Following Percutaneous Coronary Intervention: A Retrospective Analysis Using Administrative Claims Data in the United States

Presenter: David P. Faxon, Ori Ben-Yehuda

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

Advertisement

Stable Angina Decision-making: PCI vs CABG vs OMT

Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Stable Angina: PCI vs CABG vs OMT

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

Microvascular Dysfunction Prevalent in Patients with Chest Pain, Non-Obstructive CAD

Absorb III/IV: Angina and Ischemia Hypotheses

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

TCT 102: Incidence of Angina and Chest Pain Following Percutaneous Coronary Intervention: A Retrospective Analysis Using Administrative Claims Data in the United States

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content